glp-1 ncbi Oral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes - Endotext A Comprehensive Review on the

Additionally, many patients abandon GLP-1 medications due to intolerable side effects, including nausea, vomiting, diarrhea, and fatigue

Eighty-eight percent of respondents reported having health insurance, while 12% said they did not

Both of these effects slow down the rate at which food is digested and make you feel fuller

Reflecting on the clinical implications, St-Pierre says that the findings support cautious use of GLP-1 RAs in selected patients with IBD when prescribed for approved metabolic indications, with appropriate counselling and monitoring. At the same time, she noted that the findings highlight substantial evidence gaps and believes future research should move beyond proxy outcomes and incorporate prospective, IBD-specific designs that integrate objective inflammatory measures with robust metabolic phenotyping. Moreover, there should be special considerations on the effects of GLP-1 RAs on body composition of patients with IBD, she adds